ATRO Medical is a medical device company developing a meniscus prosthesis for the medial compartment of the knee, the Trammpolin® meniscus prosthesis. This implant is meant for patients with a history of (partial) resection of the knee joint meniscus, to relief pain as a result of developing osteoarthritis
Mission statement: pain relief by replacing the damaged knee joint meniscus
Meniscus injury can be severely debilitating and may lead to osteoarthritis and the need for knee arthroplasty. Today’s treatment options are very limited resulting in a high unmet need. Partial meniscectomy does not restore full joint biomechanics and is thought to lead to knee osteoarthritis. Partial replacement is only suitable as long as the meniscal rim is intact.Allograft transplantation has severe limitations including low donor availability, high risk of infection and mismatch in sizing and is associated high socioeconomic costs.
ATRO Medical is a spin-off company from the Radboudumc and DSM Biomedical and develops the Trammpolin® meniscus prosthesis. Meniscus damage and wear are important causes of Osteoarthritis of the knee. The Trammpolin®
device intends to replace the damaged meniscus with an implantable prosthesis, with the aim of restoring the protective function of the meniscus by acting as a joint spacer. The company is addressing a large unmet medical need, as an increasing number of patients with knee injuries undergo meniscectomy (partial or total removal of the meniscus). These patients gradually develop osteoarthritis, resulting in pain and reduced mobility. Current treatment options for these patients are limited and have poor outcomes. Trammpolin® aims to provide a cost-effective solution to reduce pain and restore mobility.